These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099 [TBL] [Abstract][Full Text] [Related]
4. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression. McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience. Costanzo-Nordin MR; O'Sullivan EJ; Hubbell EA; Zucker MJ; Pifarre R; McManus BM; Winters GL; Scanlon PJ; Robinson JA J Heart Transplant; 1989; 8(4):288-95. PubMed ID: 2504895 [TBL] [Abstract][Full Text] [Related]
6. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus anti-thymocyte globulin as induction therapy after heart transplantation. Bonaros N; Dunkler D; Kocher A; Imhof M; Grimm M; Zuckermann A; Wolner E; Laufer G J Heart Lung Transplant; 2006 Sep; 25(9):1154-63. PubMed ID: 16962480 [TBL] [Abstract][Full Text] [Related]
7. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis. Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838 [TBL] [Abstract][Full Text] [Related]